References
- Zarei S , CarrK, ReileyLet al. A comprehensive review of amyotrophic lateral sclerosis. Surg. Neurol. Int., 6(171), (2015).
- Kiernan MC , VucicS, CheahBCet al. Amyotrophic lateral sclerosis. Lancet, 377(9769), 942–955 (2011).
- Hardiman O , VanDen Berg LH, KiernanMC. Clinical diagnosis and management of amyotrophic lateral sclerosis. Nat. Rev. Neurol., 7(11), 639–649 (2011).
- Bhaskar S , BradleyS, Israeli-KornSet al. Chronic neurology in COVID-19 era: clinical considerations and recommendations from the REPROGRAM consortium. Front. Neurol., 11(664), 1–13 (2020).
- Adams J , LeeM, PengW. Critical review of complementary and alternative medicine use in amyotrophic lateral sclerosis: prevalence and users’ profile, decision-making, information seeking, and disclosure in the face of a lack of efficacy. Neurodegener. Dis., 18(4), 225–232 (2018).
- Wasner M , KlierH, BorasioGD. The use of alternative medicine by patients with amyotrophic lateral sclerosis. J. Neurol. Sci., 191(1–2), 151–154 (2001).
- Motor Neurone Disease Association . Examining the impact of the COVID-19 pandemic on people with MND (2020). www.mndassociation.org/research/get-involved-in-research/take-part-in-research/impact-of-covid-19-survey/
- Hogden A , FoleyG, HendersonRD, JamesN, AounSM. Amyotrophic lateral sclerosis: improving care with a multidisciplinary approach. J. Multidiscip. Healthc., 10, 205–215 (2017).
- Rooney J , ByrneS, HeverinMet al. A multidisciplinary clinic approach improves survival in ALS: a comparative study of ALS in Ireland and Northern Ireland. J. Neurol. Neurosurg. Psychiatry, 86(5), 496–501 (2015).
- Van Den Berg JP , KalmijnS, LindemanEet al. Multidisciplinary ALS care improves quality of life in patients with ALS. Neurology, 65(8), 1264–1267 (2005).
- Andersen PM , AbrahamsS, BorasioGDet al. EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS) – revised report of an EFNS task force. Eur. J. Neurol., 19(3), 360–375 (2012).
- Pan W , ChenX, BaoJet al. The use of integrative therapies in patients with amyotrophic lateral sclerosis in Shanghai, China. Eviden. Based Complement. Alternat. Med., 2013, 613596 (2013).
- Kim S , MunS, ParkJ, ChoiS, LeeS, KimS. Complementary and alternative medicine use in amyotrophic lateral sclerosis cases in South Korea. Eviden. Based Complement. Alternat. Med., 2019, 4217057 (2019).
- Abdul-Aziz NA , TohTH, GohKJet al. Natural history and clinical features of ALS in Malaysia. Amyotroph. Lateral Scler. Frontotemporal. Degener., 22(1-2), 108–116 (2021).
- Bae JS , HongYH, BaekWet al. Current status of the diagnosis and management of amyotrophic lateral sclerosis in Korea: a multi-center cross-sectional study. J. Clin. Neurol., 8(4), 293–300 (2012).
- Braga AC , GromichoM, PintoS, DeCarvalho M, HenningF. A comparative study of South African and Portuguese amyotrophic lateral sclerosis cohorts. J. Neurol. Sci., 414, 116857 (2020).
- Dorst J , ChenL, RosenbohmAet al. Prognostic factors in ALS: a comparison between Germany and China. J. Neurol., 266(6), 1516–1525 (2019).
- Deloitte Access Economics . Economics analysis of Motor Neurone Disease in Australia. Report for Motor Neurone Disease Australia, Deloitte Access Economics, Canberra (2015). www.mndaust.asn.au/Discover-our-research/Latest-research/Statistics
- Tew CW , TanLF, LuoN, NgWY, YapP. Why family caregivers choose to institutionalize a loved one with dementia: a Singapore perspective. Dement. Geriatr. Cogn. Disord., 30(6), 509–516 (2010).
- Chiu L , ShyuWC, LiuYH, WangSP, ChangTP. Factors determining the attitudes of family caregivers of dementia patients toward nursing home placement in Taiwan: comparisons between urban and semiurban areas. Public Health Nurs., 18(4), 281–291 (2001).
- World Health Organization (WHO) . Coronavirus Disease 2019 (COVID-19): situation report (2020). www.who.int/docs/default-source/coronaviruse/situation-reports/20200404-sitrep-75-covid-19.pdf?sfvrsn=99251b2b_2
- Glasmacher SA , LarrazJ, MehtaARet al. The immediate impact of the COVID-19 pandemic on motor neuron disease services and mortality in Scotland. J. Neurol., 268(6), 2038–2040 (2021).